Skip to main content
SpringerLink
Log in

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

The basal ganglia form a forebrain system that collects signals from a large part of the neocortex, redistributes these cortical inputs both with respect to one another and with respect to inputs from the limbic system, and then focuses the inputs of this redistributed, integrated signals into particular regions of the frontal lobes and brainstem involved in aspects of motor planning and motor memory. Movement disorders associated with basal ganglia dysfunction comprise a spectrum of abnormalities that range from the hypokinetic disorder (from which Parkinson’s disease, PD, is the best-known-example) at one extreme to the hyperkinetic disorder (exemplified by Huntington’s disease and hemiballism) at the other. In addition to disorders of movement, major mental disorders including schizophrenic-like states and attention deficit hyperactivity disorder (ADHD) have been linked to abnormalities in the basal ganglia and their allied nuclei.

In this paper we discuss recent evidence indicating that a dopamine-induced dysbalance of basal ganglia neurocircuitries may be an important pathophysiological component in PD. schizophrenia and ADHD. According to our model, the deprivation of dopaminergic nigrostriatal input, as in PD, reduces the positive feedback via the direct system, and increases the negative feedback via the indirect system. The critical consequences are an overactivity of the basal ganglia output sites with the resulting inhibition of thalamo-cortical drive. In schizophrenia the serious cognitive deficits might be partly a result of a hyperactivity of the inhibitory dopamine D2 transmission system. Through this dysinhibition, the thalamus exhibits hyperactivity that over stimulates the cortex resulting in dysfunctions of perception, attention, stimulus distinction, information processing and affective regulation (inducing hallucinations and delusions) and motor disabilities. Recent studies have strongly suggested that a disturbance of the dopaminergic system is also involved in the pathophysiology of ADHD. The most convincing evidence comes from the demonstration of the efficacy of psychostimulants such as the dopamine transporter (DAT) blocker methylphen-idate in the symptomatic treatment of ADHD. Genetic studies have shown an association between ADHD and genes involved in dopaminergic neurotransmission (for example the dopamine receptor genesDRD4 andDRD5, and the DAT geneDAT1). DAT knockout mice display a phenotype with increased locomotor activity, which is normalized by psychostimulant treatment. Finally, imaging studies demonstrated an increased density of DAT in the striatum of ADHD patients. Which system is disturbed and whether this system is hyper- or hypoactive is not unambiguously known yet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aarsland D, C Ballard, PJ Larsen and E McKeith (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia.Int. J. Geriatr. Psychiatry 16, 528–536.

    Article  PubMed  CAS  Google Scholar 

  • Alexander GE and MD Crutcher (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing.Trends Neurosci. 13, 266–271.

    Article  PubMed  CAS  Google Scholar 

  • Alexander GE, MR DeLong and PL Strick (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex.Ann. Rev. Neurobiol. 9, 357–381.

    Article  CAS  Google Scholar 

  • Arnulf I, AM Bonnet, P Damier, BP Bejjani, D Seilhean, JP Derenne and Y Agid (2000) Hallucinations, REM sleep and Parkinson’s disease.Neurology 55, 281–288.

    PubMed  CAS  Google Scholar 

  • Arnulf I, E Konofal, M Merino-Andreu, JL Houeto, V Mesnage, ML Welter, L Lacomblez, JL Golmard, JP Derenne and Y Agid (2002) Parkinson’s disease and sleepiness. An integral part of PD.Neurology 58, 1019–1024.

    PubMed  CAS  Google Scholar 

  • Asarnow RF, KH Nuechterlein, KL Subotnik, DL Fogelson, RD Torquato, DL Payne, J Asamen, J Mintz and D Guthrie (2002) Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles, Family Study.Arch. Gen. Psychiatry 59, 1053–1060.

    Article  PubMed  Google Scholar 

  • Badura F, GE Trott, C Mehler, P Scheuerpflug, E Hofmann, M Warmuth-Metz, M Nadjmi, L Solymosi and A Warnke (2001) A study of cranial computer tomograms in very early and early onset schizophrenia.J. Neural Transm. 108, 1335–1344.

    Article  PubMed  CAS  Google Scholar 

  • Barnes J, L Boubert, J Harris, A Lee and AS David (2003) Reality monitoring and visual hallucinations in Parkinson’s disease.Neurpsychologia 41, 565–574.

    Article  CAS  Google Scholar 

  • Bergman H, T Wichman and MR DeLong (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.Science 249, 1436–1438.

    Article  PubMed  CAS  Google Scholar 

  • Bernheimer H, W Birkmayer, O Hornykiewicz, K Jellinger and F Seitelberger (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations.J. Neurol. Sci. 20, 415–445.

    Article  PubMed  CAS  Google Scholar 

  • Biederman J and SV Faraone (2005) Attention-deficit hyperactivity disorder.Lancet 366, 237–248.

    Article  PubMed  Google Scholar 

  • Boks MPM, PF Liddle, JGM Burgerrhof, R Knegtering and RJ van den Bosch (2004) Neurological soft signs discriminating mood disorders from first episode schizophrenia.Acta Psychiatr. Scand. 110, 29–35.

    Article  PubMed  CAS  Google Scholar 

  • Cadet JL and JB Lohr (1989) Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.Ann. NYAcad. Sci. 570, 176–185.

    Article  CAS  Google Scholar 

  • Carlsson A (1977) Does dopamine plays a role in schizophrenia?Psychol. Med. 7, 583–597.

    Article  PubMed  CAS  Google Scholar 

  • Carlsson ML (2000) On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions.Acta Psychiatr. Scand. 102, 401–413.

    Article  PubMed  CAS  Google Scholar 

  • Carlsson A (2006) The neurochemical circuitry of schizophrenia.Pharmacopsychiatry 39 [Suppl. 1], S10-S14.

    Article  PubMed  CAS  Google Scholar 

  • Carlsson M and A Carlsson (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia- implications for schizophrenia and Parkinson’s disease.Trends Neurosci. 13, 272–276.

    Article  PubMed  CAS  Google Scholar 

  • Casey DE (2004) Pathophysiology of antipsychotic drug-induced movement disorders.J. Clin. Psychiatry [Suppl. 9]65, 25–28.

    PubMed  CAS  Google Scholar 

  • Cools R, E Stefanova, RA Barker, TW Robbins and AM Owen (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET.Brain 125, 584–594.

    Article  PubMed  Google Scholar 

  • Cortese L, MP Caligiuri, AK Malla, R Manchanda, J Takhar and R Haricharan (2005) Relationship of neuromotor disturbances to psychosis symptoms in first-episode neurolepticnaïve schizophrenia patients.Schizophr. Res. 75, 65–75.

    Article  PubMed  Google Scholar 

  • DeLong MR (1990) Primate models of movement disorders of basal ganglia origin.Trends Neurosci. 13, 281–285.

    Article  PubMed  CAS  Google Scholar 

  • De Rijk MC, C Tzourio, MMB Breteler, JF Dartigues, L Amaducci, S Lopez-Pousa, JM Manubens-Bertran, A Alperovitchand WA Rocca (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe. The EUROPARKINSON collaborative study.J. Neurol. Neurosurg. Psychiatry 63, 10–15.

    Article  Google Scholar 

  • Decker MJ, G Keating, GE Hue, AA Freeman and DB Rye (2002) Mesolimbic dopamine’s modulation of REM sleep.J. Sleep Res. [Suppl. 1]11, 51–52.

    Google Scholar 

  • Eisensehr I, R Linke, S Noachtar, J Schwarz, FJ Gildehaus and K Tatsch (2000) Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder. Comparison with Parkinson’s disease and controls.Brain 123, 1155–1160.

    Article  PubMed  Google Scholar 

  • Elman I, M Sigler, J Kronenberg, JP Lindenmayer, A Doron, S Mendlovic and B Gaoni (1998) Characteristics of patients with schizophrenia successive to childhood attention deficit hyperactivity disorder. Isr.J. Psychiatry Relat. Sci. 35, 280–286.

    CAS  Google Scholar 

  • Faraone SV and J Biederman (1998) Neurobiology of attention-deficit hyperactivity disorder.Biol. Psychiatry 44, 951–958.

    Article  PubMed  CAS  Google Scholar 

  • Farmer AE and P McGuffin (1988) The pathogenesis and management of schizophrenia.Drugs 35, 177–185.

    Article  PubMed  CAS  Google Scholar 

  • Foley P and P Riederer (2000) The motor circuit of the human basal ganglia reconsidered.J. Neural Transm. (Suppl.)58, 97–110.

    Google Scholar 

  • Francois C, D Grabli, K McCairn, C Jan, C Karachi, E-C Hirsch, J Feger and L Tremblay (2004) Behavioural disorders induced by external globus pallidus dysfunction in primates - II. Anatomical study.Brain 127, 2055–2070.

    Article  PubMed  Google Scholar 

  • Gainetdinov RR and MC Caron (2001) Genetics of childhood disorders: XXIV. ADHD, part 8: Hyperdopaminergic mice as an animal model of ADHD.J. Am. Acad. Child. Adolesc. Psychiatry 40, 380–382.

    Article  PubMed  CAS  Google Scholar 

  • Gerring J, K Brady, A Chen, C Quinn, E Herskovits, K Bandeen-Roche, MB Denckla and RN Bryan (2000) Neuroimaging variables related to development of secondary attention deficit hyperactivity disorder after closed injury in children and adolescents.Brain Inj. 14, 205–218.

    Article  PubMed  CAS  Google Scholar 

  • Gottesman II and TD Gould (2003) The endophenotype concept in psychiatry: etymology and strategic intentions.J. Am. Psychiatry 160, 636–645.

    Article  Google Scholar 

  • Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia.Trends Neuosci. 13, 244–264.

    Article  CAS  Google Scholar 

  • Heiser P, S Friedel, A Dempfle, K Konrad, J Smidt, J Grabarkiewicz, B Herpertz-Dahlmann, H Remschmidt and J Hebebrand (2004) Molecular genetic aspects of attention-deficit/ hyperactivity dsisorder.Neurosci. Biobehav. Rev. 28, 625–641.

    Article  PubMed  CAS  Google Scholar 

  • Herzog J, J Reiff, P Krack, K Witt, B Schrader, D Müller and G Deuschl (2003) Manic episode with psychotic symptoms by subthalamic nucleus stimulation in a patient with Parkinson’s disease.Mov. Disord. 18, 1382–1384.

    Article  PubMed  Google Scholar 

  • Holroyd S, L Currie and GF Wooten (2001) Prospective study of hallucinations and delusions in Parkinson’s disease.J. Neurol. Neurosurg. Psychiatry 70, 734–738.

    Article  PubMed  CAS  Google Scholar 

  • Honer WG, LC Kopala and J Rabinowitz (2005) Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.J. Psychopharmacol. 18, 277–285.

    Article  Google Scholar 

  • Ismail MS and IH Richard (2004) A reality test: how well do we understand psychosis in Parkinson’s disease?J. Neuropsychiatry Clin. Neurosci. 16, 8–18.

    PubMed  Google Scholar 

  • Janno S, M Holi, K Tuisku and K Wahlbeck (2004) Prevalence of neuroleptic-induced disorders in chronic schizophrenia patients.Am. J. Psychiatry 161, 160–163.

    Article  PubMed  Google Scholar 

  • Jellinger K (1989) Pathology of Parkinson’s syndrome, In:Handbook of Experimental Pharmacology, Vol.88 (Calne DB, Ed.) (Springer:Berlin, Heidelberg), pp 47–112.

    Google Scholar 

  • Jenkins BG, R Sanchez-Pernaute, AL Brownell, IC Yin-Ching and O Isacson (2004) Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.J. Neurosci. 24, 9553–9560.

    Article  PubMed  CAS  Google Scholar 

  • Keshavan MS (1999) Development, disease and degeneration in schizophrenia: a unitary pathophysiological model.J. Psychiatr. Res. 33, 513–521.

    Article  PubMed  CAS  Google Scholar 

  • Keshavan MS, M Sujata, A Mehra, DM Montrose and JA Sweeney (2003) Psychosis proneness and ADHD in young relatives of schizophrenia patients.Schizophr. Res. 59, 85–92.

    Article  PubMed  Google Scholar 

  • Klawans HL and R Rubovitz (1972) An experimental model of tardive dyskinesia.J. Neural Transm. 33, 235–246.

    Article  PubMed  Google Scholar 

  • Krause KH, SH Dresel, J Krause, HF Kung and K Tatsch (2001) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.Neurosci. Lett. 285, 107–110.

    Article  Google Scholar 

  • Kulisevsky J (2000) Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson’s disease.Drugs Aging 16, 365–379.

    Article  PubMed  CAS  Google Scholar 

  • Laitinen LV (1995) Pallidotomy for Parkinson’s disease.Neurosurg. Clin. N. Am. 6, 105–112.

    PubMed  CAS  Google Scholar 

  • Larisch R, W Sitte, C Antke, S Nikolaus, M Franz, W Tress and H-W Müller (2006). Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder.Nucl. Med. Commun. 27, 267–270.

    Article  PubMed  Google Scholar 

  • Laruelle M, WG Frankle, R Narendran, LS Kegeles and A Abi-Dargham (2005) Mechanism of action of antipsychotic drugs: from dopamine D2 receptor antagonism to glutamate NMDA facilitation.Clin. Ther. (Suppl. A) 27, S16-S24.

    CAS  Google Scholar 

  • Lencer R, G Eismann, M Kasten, K Kabakci, V Geithe, J Grimm and CH Klein (2004) Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms.Brit. J. Psychiatry 185, 465–471.

    Article  Google Scholar 

  • Lencz T, CW Smith, A Auther, CU Correll and B Cornblatt (2004) Nonspecific and attenuated symptoms in patients at clinical high-risk for schizophrenia.Schizophr. Res. 68, 37–48.

    Article  PubMed  Google Scholar 

  • Limousin P, P Pollak, A Benazzouz, D Hoffmann, JF Le Bas, E Broussolle, JE Perrett and AL Benabid (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic stimulation.Lancet 345, 91–95.

    Article  PubMed  CAS  Google Scholar 

  • Lou HC, L Henriksen, P Bruhn, H Borner and JB Nielsen (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder.Arch. Neurol. 46, 48–52.

    PubMed  CAS  Google Scholar 

  • Marsden CD (1990) Parkinson’s disease.Lancet 335, 948–952.

    Article  PubMed  CAS  Google Scholar 

  • Marsh L, JR Williams, M Rocco, S Grill, C Munro and TM Dawson (2004) Psychiatric comorbidities in patients with Parkinson disease and psychosis.Neurology 63, 293–300.

    PubMed  CAS  Google Scholar 

  • Max JE, PT Fox, JL Lancaster, P Kochunov, K Mathews, FF Manes, BA Robertson, S Arndt, DA Robin and AE Lansing (2002) Putamen lesions and the development of attentiondeficit/ hyperactivity symptomatology.J. Am. Acad. Child. Adolesc. Psychiatry 41 (5), 563–571.

    Article  PubMed  Google Scholar 

  • McCreadie RG, R Thara, TN Srinivasan and R Padmavathi (2003) Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia.Br. J. Psychiatry 183, 45–49.

    Article  PubMed  Google Scholar 

  • Mehler C and A Warnke (2002) Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques.J. Neural Transm. 109, 219–234.

    Article  PubMed  CAS  Google Scholar 

  • Narabayashi H, F Yokochi and Y Nakajima (1984) Levodopainduced dyskinesia and thalatomy.J. Neurol. Neurosurg. Psychiatry 47, 831–839.

    Article  PubMed  CAS  Google Scholar 

  • Opler LA, DM Frank and PM Ramirez (2001) Psychostimulants in the treatment of adults with psychosis and attention deficit disorder.Ann. NY Acad. Sci. 297–301.

  • Pappert EJ, GG Goetz, FG Niederman, R Raman and S Leurgans (1999) Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease.Mov. Disord. 14, 117–121.

    Article  PubMed  CAS  Google Scholar 

  • Pauletto G, E Belgrado, R Marinig and P Bergonzi (2004) Sleep disorders and extrapyramidal diseases: a historical review.Sleep Med. 5, 163–167.

    Article  PubMed  CAS  Google Scholar 

  • Perry E, M Walker, J Grace and R Perry (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness?Trends Neurosci. 22, 273–280.

    Article  PubMed  CAS  Google Scholar 

  • Pine DS, RG Klein, DC Lindy and RD Marshall (1994) Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations.J. Clin. Psychiatry 54, 312–313.

    Google Scholar 

  • Riederer P and S Wuketich (1976) Time course of nigrostriatal degeneration in Parkinson’s disease. A detailed study of influential factors in human brain amine analysis.J. Neural Transm. 38, 277–301.

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, KW Lange, J Kornhuber and W Danielczyk (1992) Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.Arzneimittelforsch. 42, 265–268.

    PubMed  CAS  Google Scholar 

  • Rubia K, S Overmeyer, E Taylor, M Brammer, SCR Williams, A Simmons and ET Bullmore (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.Am. J. Psychiatry 156, 891–896.

    PubMed  CAS  Google Scholar 

  • Sanchez-Ramos JR, R Ortoll R and GW Paulson (1996) Visual hallucinations associated with Parkinson disease.Arch. Neurol. 53(12), 1265–1268.

    Google Scholar 

  • Schafer D and W Greulich (2000) Effects of parkinsonian medications on sleep.J. Neurol. 247, 24–27.

    Article  Google Scholar 

  • Shafritz KM, KE Marchione, JC Gore, SE Shaywitz and BA Shaywitz (2004) The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.Am. J. Psychiatry 161, 1990–1997.

    Article  PubMed  Google Scholar 

  • Sian J, M Gerlach, MBH Youdim and P Riederer (1999) Parkinson’s disease: a major hypokinetic basal ganglia disorder.J. Neural Transm. 106, 443–476.

    Article  PubMed  CAS  Google Scholar 

  • Srinivasan TN, R Thara, R Padmavathi and RG McCreadie (2001) Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.Schizophr. Res. 47, 69–75.

    Article  PubMed  CAS  Google Scholar 

  • Steen VM, R Lovlie and T McEwan (1997) Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.Mol. Psychiatry 2, 139–145.

    Article  PubMed  CAS  Google Scholar 

  • Sullivan RM and WG Brake (2003) What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function.Behav. Brain Res. 146, 43–55.

    Article  PubMed  Google Scholar 

  • Takakusaki K, K Saitoh, H Harada, T Okumura and T Sakamoto (2004) Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegemental nucleus and the substantia nigra pars reticulata in decerebrate rats.Neuroscience 124, 207–220.

    Article  PubMed  CAS  Google Scholar 

  • Thanvi BR, SK Munshi, N Vijaykumar and TCN Lo (2003) Neuropsychiatric non-motor aspects of Parkinson’s disease. Review.Postgrad. Med. J. 79, 561–565.

    Article  PubMed  CAS  Google Scholar 

  • The Deep-Brain Stimulation for Parkinson’s Disease Study Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease.N. Engl. J. Med. 345, 956–963.

    Article  Google Scholar 

  • Thompson PM, C Vidal, JN Giedd, P Gochman, J Blumenthal, R Nicolson, AW Toga and JL Rapoport (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early onset schizophrenia.Proc. Natl. Acad. Sci. USA 98, 11650–11655.

    Article  PubMed  CAS  Google Scholar 

  • Vaidya CJ, G Austin, G Kirkorian, HW Ridlehuber, JE Desmond, GH Glover and JDE Gabrieli (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.Proc. Natl. Acad. Sci. USA 95, 14494–14499.

    Article  PubMed  CAS  Google Scholar 

  • Volkow ND, GJ Wang, JS Fowler, J Logan, M Gerasimov, L Maynard, YS Ding, S J Gatley, A Gifford and D Franceschi (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.J. Neurosci. 2, U1-U5.

    Google Scholar 

  • Wint DP, MS Okun and HH Fernandez (2004) Psychosis in Parkinson’s diesease.Psychiatry Neurol. 17, 127–136.

    Article  Google Scholar 

  • Wonody I, HM Adami, SL Cassady, JD Sherr, MT Avila and GK Thaker (2004) Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland Psychiatric Research Center.J. Clin. Psychopharm-acol. 24, 592–598.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child and Adolescent Psychiatry and Psychotherapy, Julius- Maximilians- University, Wuerzburg, Germany

    C. Mehler-Wex & M. Gerlach

  2. Clinical Neurochemistry, Department of Psychiatry and Psychotherapy, Julius- Maximilians- University, Wuerzburg, Germany

    P. Riederer

Authors
  1. C. Mehler-Wex
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Riederer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehler-Wex, C., Riederer, P. & Gerlach, M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder. neurotox res 10, 167–179 (2006). https://doi.org/10.1007/BF03033354

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033354

Keywords

Search

Navigation